NASDAQ · Key Statistics

Protagenic Therapeutics, Inc. (PTIX) Key Statistics

$0.26 NASDAQ: PTIX Market Cap $470654

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Protagenic Therapeutics, Inc. (PTIX), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	-0.08
P/B ratioShare price divided by book value per share.	-0.21
P/S ratioMarket value divided by annual revenue.	0.00
PEG ratioP/E divided by the earnings growth rate.	0.00
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.	-0.18
EV / RevenueEnterprise value against annual revenue.	0.00
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.	-1250.00%
Free cash flow yieldFree cash flow as a percentage of market value.	-879.70%
Price / free cash flowMarket value divided by free cash flow.	-0.11

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	0.00%
Operating marginRevenue left after operating costs.	0.00%
Net marginRevenue left after every cost, including tax and interest.	0.00%
Return on equityProfit as a percentage of shareholders’ equity.	184.88%
Return on assetsProfit as a percentage of total assets.	-241.84%
Return on capital employedOperating profit against the capital the business uses.	124.29%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	0.34
Quick ratioThe same, excluding inventory.	0.34
Cash ratioCash alone against current liabilities.	0.29
Debt to equityTotal borrowings against shareholders’ equity.	-1.32
Debt to assetsTotal borrowings against total assets.	1.50
Interest coverageHow many times operating profit covers the interest bill.	-21.36

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$-3.45
Book value per shareShareholders’ equity divided by shares outstanding.	$-2.42
Shares outstandingShares currently issued.	0
Market capitalisationShare price times shares outstanding.	$470654
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.	$1.47M

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	0.00%
Payout ratioShare of profit paid out as dividends.	0.00%

Protagenic Therapeutics, Inc. (PTIX) statistics — frequently asked questions

What is Protagenic Therapeutics, Inc.'s P/E ratio?

Protagenic Therapeutics, Inc. (PTIX) trades on a price-to-earnings ratio of -0.08. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is Protagenic Therapeutics, Inc.'s return on equity?

Protagenic Therapeutics, Inc. (PTIX) reports a return on equity of 184.88%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does Protagenic Therapeutics, Inc. carry?

Protagenic Therapeutics, Inc. (PTIX) has a debt-to-equity ratio of -1.32, which compares total borrowings with shareholders' equity.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.